Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-07-000158
Filing Date
2007-02-15
Accepted
2007-02-14 17:34:01
Documents
2
Group Members
ANDREEFF EQUITY ADVISORS, L.L.C.MAPLE LEAF CAPITAL, L.L.C.MAPLE LEAF OFFSHORE FUND, LTD.MAPLE LEAF PARTNERS, L.P.

Document Format Files

Seq Description Document Type Size
1 ardea_sc13g.txt SC 13G 20112
2 EXHIBIT A exhibit-a.txt EX-99 2125
  Complete submission text file 0000898432-07-000158.txt   24444
Mailing Address 1009 OAK HILL ROAD SUITE 201 LAFAYETTE CA 94549
Business Address 1009 OAK HILL ROAD SUITE 201 LAFAYETTE CA 94549 650-845-6200
Ardea Biosciences, Inc./DE (Subject) CIK: 0001103390 (see all company filings)

EIN.: 943200380 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-59411 | Film No.: 07623422
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL ST STE 2105 BATON ROUGE LA 70801
Business Address C/O ANDREEFF EQUITY ADVISORS LLC 450 LAUREL STREET STE 2105 BATON ROUGE LA 70801 2253447780
ANDREEFF DANE (Filed by) CIK: 0001201810 (see all company filings)

Type: SC 13G